Attributable cost and length of stay for patients with central venous catheter -: Associated bloodstream infection in Mexico city intensive care units:: A prospective, matched analysis

被引:96
作者
Higuera, Francisco
Rangel-Frausto, Manuel Sigfrido
Rosenthal, Victor Daniel
Soto, Jose Martinez
Castanon, Jorge
Franco, Guillermo
Tabal-Galan, Natividad
Ruiz, Javier
Duarte, Pablo
Graves, Nicholas
机构
[1] Coll Med, RA-1405 Buenos Aires, DF, Argentina
[2] Gen Hosp, Mexico City, DF, Mexico
[3] Inst Mexicano Seguro Social Hosp, Mexico City, DF, Mexico
[4] Gabriel Mancera IMSS Hosp, Mexico City, DF, Mexico
[5] Queensland Univ Technol, Sch Publ Hlth, Queenstown, MD USA
关键词
D O I
10.1086/510812
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
Background. No information is available about the financial impact of central venous catheter (CVC)-associated bloodstream infection (BSI) in Mexico. Objective. To calculate the costs associated with BSI in intensive care units ( ICUs) in Mexico City. Design. An 18-month ( June 2002 through November 2003), prospective, nested case-control study of patients with and patients without BSI. Setting. Adult ICUs in 3 hospitals in Mexico City. Patients and methods. A total of 55 patients with BSI ( case patients) and 55 patients without BSI ( control patients) were compared with respect to hospital, type of ICU, year of hospital admission, length of ICU stay, sex, age, and mean severity of illness score. Information about the length of ICU stay was obtained prospectively during daily rounds. The daily cost of ICU stay was provided by the finance department of each hospital. The cost of antibiotics prescribed for BSI was provided by the hospitals' pharmacy departments. Results. For case patients, the mean extra length of stay was 6.1 days, the mean extra cost of antibiotics was $598, the mean extra hospital cost was $11,591, and the attributable extra mortality was 20%. Conclusions. In this study, the duration of ICU stay for patients with central venous catheter-associated BSI was significantly longer than that for control patients, resulting in increased healthcare costs and a higher attributable mortality. These conclusions support the need to implement preventive measures for hospitalized patients with central venous catheters in Mexico.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 44 条
[1]
Balows A., 1991, MANUAL CLIN MICROBIO
[2]
The history of the drug utilization research group in Europe [J].
Bergman, U .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (02) :95-98
[3]
INTRAVASCULAR CATHETER-ASSOCIATED SEPSIS - A COMMON PROBLEM [J].
COLLIGNON, PJ .
MEDICAL JOURNAL OF AUSTRALIA, 1994, 161 (06) :374-378
[4]
The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices [J].
Crnich, CJ ;
Maki, DG .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) :1232-1242
[5]
The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices [J].
Crnich, CJ ;
Maki, DG .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (10) :1362-1368
[6]
Crnich CJ, 2002, J CRIT ILLNESS, V17, P48
[7]
The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive cave unit [J].
DiGiovine, B ;
Chenoweth, C ;
Watts, C ;
Higgins, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) :976-981
[8]
Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit [J].
Dimick, JB ;
Pelz, RK ;
Consunji, R ;
Swoboda, SM ;
Hendrix, CW ;
Lipsett, PA .
ARCHIVES OF SURGERY, 2001, 136 (02) :229-234
[9]
Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients [J].
Elward, AM ;
Hollenbeak, CS ;
Warren, DK ;
Fraser, VJ .
PEDIATRICS, 2005, 115 (04) :868-872
[10]
CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140